This topic contains a solution. Click here to go to the answer

Author Question: This type of organization is not defined by, or limited to, the horizontal, vertical, or external ... (Read 39 times)

Yi-Chen

  • Hero Member
  • *****
  • Posts: 550
This type of organization is not defined by, or limited to, the horizontal, vertical, or external boundaries imposed by a predefined structure.
◦ Independent business unit
◦ Work team structures
◦ Informal structure
◦ Boundaryless organizations


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by Yi-Chen on Mar 10, 2019

onowka

  • Sr. Member
  • ****
  • Posts: 353
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 29% of students answer this correctly




Yi-Chen

  • Member
  • Posts: 550
Reply 2 on: Mar 10, 2019
:D TYSM


TheDev123

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library